Agfa’s proposed acquisition of Sterling Diagnostic Imaging received the go-ahead from regulatory authorities in the U.S. and Europe, the companies reported this month. Executives from the firms believe that the merger should be completed by the
Agfas proposed acquisition of Sterling Diagnostic Imaging received the go-ahead from regulatory authorities in the U.S. and Europe, the companies reported this month. Executives from the firms believe that the merger should be completed by the middle of May, pending shareholder approval (SCAN 1/20/99). Agfas spin-off from Bayer could come as soon as a month later, with Bayer setting a deadline of June 1 for the divestiture of its Mortsel, Belgium-based subsidiary, according to Bloomberg News.
Sterling of Greenville, SC, is also reportedly close to reaching a deal to sell off its Direct Radiography Corp. digital x-ray subsidiary, which is not part of the Agfa sale. Sources close to Sterling say that it has received bids from a number of prospective suitors for DRC, and plans to make a decision in the next several weeks.
Can MRI-Based AI Enhance Pre-Op Prediction of Tumor Deposits in Patients with Rectal Cancer?
October 31st 2024For patients with rectal cancer, an emerging nomogram that combines deep learning and clinical factors had greater than 16 percent and 23 percent increases in accuracy and specificity, respectively, for pre-op prediction of tumor deposits in comparison to clinical factors alone.
Artifact Reduction Drives Technology Advances with Updated Version of Echelon Synergy MRI System
October 30th 2024Emerging technologies included with the 10th version of the 1.5T MRI platform include Synergy DLR Clear and Synergy Vision that are geared toward mitigating common challenges with artifacts.